A detailed history of Angelo Gordon & Co., L.P. transactions in Surmodics Inc stock. As of the latest transaction made, Angelo Gordon & Co., L.P. holds 21,160 shares of SRDX stock, worth $841,110. This represents 0.6% of its overall portfolio holdings.

Number of Shares
21,160
Previous 25,000 15.36%
Holding current value
$841,110
Previous $1.05 Million 21.98%
% of portfolio
0.6%
Previous 0.84%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$38.47 - $42.24 $147,724 - $162,201
-3,840 Reduced 15.36%
21,160 $820,000
Q2 2024

Aug 13, 2024

BUY
$25.39 - $42.1 $634,750 - $1.05 Million
25,000 New
25,000 $1.05 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $557M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Angelo Gordon & Co., L.P. Portfolio

Follow Angelo Gordon & Co., L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Angelo Gordon & Co., L.P., based on Form 13F filings with the SEC.

News

Stay updated on Angelo Gordon & Co., L.P. with notifications on news.